Sofimac Innovation

Sofimac Partners is a seasoned French venture capital and private equity firm with a focus on supporting high-growth SMEs and innovative startups. Established over 40 years ago, the firm specializes in early-stage investments, particularly in sectors like life sciences, healthtech, deeptech, and industrial engineering. Based in cities like Paris, Lyon, Rennes, and Marseille, Sofimac has an extensive national presence, allowing it to stay close to key innovation hubs across France. Sofimac manages over €750 million in assets, with a portfolio of more than 90 active companies. Their investment strategy focuses on early-stage startups, often providing seed to Series A funding with ticket sizes ranging from €100,000 to €2 million. They are also committed to long-term partnerships, with the ability to follow on in subsequent rounds, supporting startups through their growth journey. Notable companies in their portfolio include Diabeloop, an innovator in diabetes management, and Mob-Energy, which develops robotic electric vehicle charging solutions. The firm also runs the Pertinence Invest 2 fund, which specifically targets disruptive technologies emerging from academic research, particularly in healthcare and engineering. With a hands-on approach, Sofimac works closely with founders, offering not just capital but strategic guidance and access to a broad network of industry experts and institutional partners.